Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Hamilton

Showing results (151-160 of 180) with videos related to

Pageof 18
Sort By:
Acta Oncologica (Stockholm, Sweden)|September 3, 2021
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorderTrine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.
Annals of Medicine and Surgery (2012)|November 14, 2015
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverLin Nanna Okholm Møller, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Journal of Hepatology|July 8, 2018
Urea cycle dysregulation in non-alcoholic fatty liver diseaseFrancesco De Chiara, Sara Heebøll, Giusi Marrone, et al.
Plos One|April 11, 2023
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in DenmarkTapashi Dalvi, Mette Nørgaard, Jon P Fryzek, et al.
Cancer Epidemiology|July 4, 2021
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in DenmarkElizabeth Hedgeman, Mette Nørgaard, Tapashi Dalvi, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Pageof 18

Showing results (151-160 of 180) with videos related to

Sort By:
Pageof 18
Acta Oncologica (Stockholm, Sweden)|September 3, 2021
Intratumoral expression of CD38 in patients with post-transplant lymphoproliferative disorderTrine Engelbrecht Hybel, Maja Ølholm Vase, Eva Futtrup Maksten, et al.
JHEP Reports : Innovation in Hepatology|February 28, 2024
Cognitive dysfunction in early experimental metabolic dysfunction-associated steatotic liver disease is associated with systemic inflammation and neuroinflammationKristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Anne M Landau, et al.
Annals of Medicine and Surgery (2012)|November 14, 2015
Anti-CD163-dexamethasone protects against apoptosis after ischemia/reperfusion injuries in the rat liverLin Nanna Okholm Møller, Anders Riegels Knudsen, Kasper Jarlhelt Andersen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 14, 2011
Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivorsThomas P Ahern, Mariann Christensen, Deirdre P Cronin-Fenton, et al.
Plos One|March 17, 2017
Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patientsDaniella Klebaner, Stephen Hamilton-Dutoit, Thomas Ahern, et al.
Breast Cancer Research : BCR|November 5, 2021
Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control studyLindsay J Collin, Maret L Maliniak, Deirdre P Cronin-Fenton, et al.
Journal of Hepatology|July 8, 2018
Urea cycle dysregulation in non-alcoholic fatty liver diseaseFrancesco De Chiara, Sara Heebøll, Giusi Marrone, et al.
Plos One|April 11, 2023
Biomarker expression and survival in patients with non-small cell lung cancer receiving adjuvant chemotherapy in DenmarkTapashi Dalvi, Mette Nørgaard, Jon P Fryzek, et al.
Cancer Epidemiology|July 4, 2021
Programmed cell death ligand-1 expression and survival in a cohort of patients with non-small cell lung cancer receiving first-line through third-line therapy in DenmarkElizabeth Hedgeman, Mette Nørgaard, Tapashi Dalvi, et al.
Breast Cancer Research and Treatment|May 14, 2025
Genetic variants in tamoxifen metabolism and early treatment discontinuation among premenopausal breast cancer patientsKirsten M Woolpert, Thomas P Ahern, James W Baurley, et al.
Pageof 18